MLTX
MoonLake Immunotherapeutics
55.26
USD
This page is just a preview of the data found in TrendSpider’s full version
MoonLake Immunotherapeutics stock is up 31.07% since 30 days ago. The next earnings date is Mar 18, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 07 Nov 15:19 | 17 Nov, 2023 | 40.00 | 138 | ||
| 07 Nov 16:31 | 17 Nov, 2023 | 50.00 | 1986 | ||
| 17 Nov 18:18 | 16 Feb, 2024 | 35.00 | 223 | ||
| 20 Nov 14:55 | 15 Dec, 2023 | 40.00 | 122 | ||
| 20 Nov 17:51 | 15 Dec, 2023 | 45.00 | 309 | ||
| 22 Nov 17:04 | 15 Dec, 2023 | 40.00 | 171 | ||
| 28 Nov 15:39 | 15 Dec, 2023 | 40.00 | 395 | ||
| 28 Nov 18:13 | 15 Dec, 2023 | 40.00 | 395 | ||
| 28 Nov 18:42 | 15 Dec, 2023 | 45.00 | 452 | ||
| 05 Dec 15:42 | 15 Dec, 2023 | 40.00 | 319 |
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, or ankylosing spondylitis.
